IDNA vs. IBIT
IDNA (iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund) and IBIT (iShares Bitcoin Trust ETF) are both exchange-traded funds - IDNA is a Health & Biotech Equities fund tracking the NYSE FactSet Global Genomics and Immuno Biopharma Index, while IBIT is a Cryptocurrency fund tracking the CME CF Bitcoin Reference Rate - New York Variant. Both are passively managed. Over the past year, IDNA returned 54.42% vs -39.82% for IBIT. At a 0.32 correlation, their price movements are largely independent. IDNA charges 0.47%/yr vs 0.25%/yr for IBIT.
Performance
IDNA vs. IBIT - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, IDNA achieves a 19.52% return, which is significantly higher than IBIT's -28.88% return.
IDNA
- 1D
- 1.53%
- 1M
- 6.29%
- YTD
- 19.52%
- 6M
- 16.84%
- 1Y
- 54.42%
- 3Y*
- 11.16%
- 5Y*
- -8.18%
- 10Y*
- —
IBIT
- 1D
- -3.26%
- 1M
- -17.81%
- YTD
- -28.88%
- 6M
- -28.88%
- 1Y
- -39.82%
- 3Y*
- —
- 5Y*
- —
- 10Y*
- —
IDNA vs. IBIT - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | |
|---|---|---|---|
IDNA iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund | 19.52% | 17.26% | -3.17% |
IBIT iShares Bitcoin Trust ETF | -28.88% | -6.41% | 89.87% |
Correlation
The correlation between IDNA and IBIT is 0.33, which is low. Their price movements are largely independent, making them effective diversification partners.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.33 |
Correlation (All Time) Calculated using the full available price history since Jan 11, 2024 | 0.32 |
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
IDNA vs. IBIT — Risk / Return Rank
IDNA
IBIT
IDNA vs. IBIT - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund (IDNA) and iShares Bitcoin Trust ETF (IBIT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| IDNA | IBIT | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | +3.09 | ||
| Sortino ratioReturn per unit of downside risk | +4.28 | ||
| Omega ratioGain probability vs. loss probability | 1.34 | 0.86 | +0.48 |
| Calmar ratioReturn relative to maximum drawdown | 5.13 | -0.77 | +5.89 |
| Martin ratioReturn relative to average drawdown | 14.30 | -1.30 | +15.60 |
Loading charts...
Drawdowns
IDNA vs. IBIT - Drawdown Comparison
The maximum IDNA drawdown since its inception was -68.26%, which is greater than IBIT's maximum drawdown of -52.11%. Use the drawdown chart below to compare losses from any high point for IDNA and IBIT.
Loading charts...
Drawdown Indicators
| IDNA | IBIT | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -68.26% | -52.11% | -16.15% |
Max Drawdown (1Y)Largest decline over 1 year | -10.66% | -52.11% | +41.45% |
Max Drawdown (3Y)Largest decline over 3 years | -29.46% | — | — |
Max Drawdown (5Y)Largest decline over 5 years | -68.26% | — | — |
Current DrawdownCurrent decline from peak | -41.07% | -50.47% | +9.40% |
Average DrawdownAverage peak-to-trough decline | -36.28% | -16.85% | -19.43% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 3.82% | 30.58% | -26.76% |
Volatility
IDNA vs. IBIT - Volatility Comparison
The current volatility for iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund (IDNA) is 7.33%, while iShares Bitcoin Trust ETF (IBIT) has a volatility of 13.18%. This indicates that IDNA experiences smaller price fluctuations and is considered to be less risky than IBIT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| IDNA | IBIT | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 7.33% | 13.18% | -5.85% |
Volatility (6M)Calculated over the trailing 6-month period | 18.45% | 34.64% | -16.19% |
Volatility (1Y)Calculated over the trailing 1-year period | 24.96% | 44.31% | -19.35% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 28.47% | 50.22% | -21.75% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 29.51% | 50.22% | -20.71% |
IDNA vs. IBIT - Expense Ratio Comparison
IDNA has a 0.47% expense ratio, which is higher than IBIT's 0.25% expense ratio.
Dividends
IDNA vs. IBIT - Dividend Comparison
IDNA's dividend yield for the trailing twelve months is around 0.90%, while IBIT has not paid dividends to shareholders.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|---|
IBIT iShares Bitcoin Trust ETF | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
IDNA iShares Genomics Immunology and Healthcare ETF Genomics Immunology and Healthcare Fund | 0.90% | 1.18% | 0.98% | 1.04% | 0.54% | 0.70% | 0.26% | 0.80% |
Frequently Asked Questions
IDNA and IBIT have a correlation of 0.33, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
IBIT has higher volatility (13.18%) compared to IDNA (7.33%). In terms of maximum drawdown, IDNA dropped -68.26% vs IBIT's -52.11%.
On 1-year performance, IDNA leads with 54.42% vs -39.82% for IBIT. On fees, IBIT is cheaper at 0.25% per year. On volatility, IDNA has been the lower-risk option at 7.33%. The better choice depends on whether you care most about return, fees, risk, or income.
Over the 1-year period, IDNA has performed better with a 54.42% return vs -39.82%. Past performance does not guarantee future results, so compare this with risk, fees, and fund exposure.
IBIT is cheaper with a 0.25% expense ratio, compared with 0.47% for IDNA.
IDNA has the higher dividend yield at 0.90%, compared with 0.00% for IBIT.
IDNA is categorized as Health & Biotech Equities, while IBIT is Cryptocurrency. IDNA tracks NYSE FactSet Global Genomics and Immuno Biopharma Index, while IBIT tracks CME CF Bitcoin Reference Rate - New York Variant. Their fees differ too: 0.47% for IDNA and 0.25% for IBIT.
IDNA currently has the higher Sharpe Ratio (2.19 vs -0.90), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for IDNA and IBIT
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer